Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer - PubMed (original) (raw)
. 2003 Oct 1;63(19):6478-87.
Affiliations
- PMID: 14559840
Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer
Evelyn Hartmann et al. Cancer Res. 2003.
Abstract
The antitumor activity of IFN-alpha is well established. However, the role of the plasmacytoid dendritic cell (PDC), the major producer of IFN-alpha upon viral infection, in tumor biology is unknown. We sought to study the presence and function of PDC in a human solid tumor. Here, we demonstrate that PDCs infiltrate tumor tissue of patients with head and neck squamous cell carcinoma (HNSCC). Functional activity of PDC was examined by using CpG motif containing oligonucleotides, a defined microbial stimulus for PDCs (recognized via toll-like receptor 9). We found that HNSCC diminished the ability of PDC to produce IFN-alpha in response to CpG motif containing oligonucleotide. Tumor-induced down-regulation of toll-like receptor 9 was identified as one mechanism likely contributing to impaired PDC function within the tumor environment. In tumor-draining lymph nodes, suppression of CpG-induced IFN-alpha production was less pronounced than in single-cell suspensions of primary tumor tissue. In these lymph nodes, CpG-induced IFN-alpha production was associated with increased levels of interferon-induced protein 10 and IFN-gamma and activation of CD4 and CD8 T cells. These results show for the first time the presence of PDCs in human solid tumor tissue and that tumors suppress the capacity of PDCs to produce IFN-alpha. PDCs, which in the absence of appropriate stimulation are reported to promote regulatory CD8 T cells, may contribute to an impaired T-cell-mediated immune response in HNSCC.
Similar articles
- Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells.
Thiel A, Pries R, Jeske S, Trenkle T, Wollenberg B. Thiel A, et al. Anticancer Res. 2009 Aug;29(8):3019-25. Anticancer Res. 2009. PMID: 19661310 - Properties regulating the nature of the plasmacytoid dendritic cell response to Toll-like receptor 9 activation.
Guiducci C, Ott G, Chan JH, Damon E, Calacsan C, Matray T, Lee KD, Coffman RL, Barrat FJ. Guiducci C, et al. J Exp Med. 2006 Aug 7;203(8):1999-2008. doi: 10.1084/jem.20060401. Epub 2006 Jul 24. J Exp Med. 2006. PMID: 16864658 Free PMC article. - Functional alteration of myeloid dendritic cells through head and neck cancer.
Brocks CP, Pries R, Frenzel H, Ernst M, Schlenke P, Wollenberg B. Brocks CP, et al. Anticancer Res. 2007 Mar-Apr;27(2):817-24. Anticancer Res. 2007. PMID: 17465207 - Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
Becker Y. Becker Y. Anticancer Res. 2006 Mar-Apr;26(2A):1113-34. Anticancer Res. 2006. PMID: 16619514 Review. - Recent advances in immunostimulatory CpG oligonucleotides.
Rothenfusser S, Tuma E, Wagner M, Endres S, Hartmann G. Rothenfusser S, et al. Curr Opin Mol Ther. 2003 Apr;5(2):98-106. Curr Opin Mol Ther. 2003. PMID: 12772497 Review.
Cited by
- Tumor-infiltrating plasmacytoid dendritic cells are associated with survival in human colon cancer.
Kießler M, Plesca I, Sommer U, Wehner R, Wilczkowski F, Müller L, Tunger A, Lai X, Rentsch A, Peuker K, Zeissig S, Seifert AM, Seifert L, Weitz J, Bachmann M, Bornhäuser M, Aust D, Baretton G, Schmitz M. Kießler M, et al. J Immunother Cancer. 2021 Mar;9(3):e001813. doi: 10.1136/jitc-2020-001813. J Immunother Cancer. 2021. PMID: 33762320 Free PMC article. - Assessment of expression of toll-like receptors 2, 3 and 4 in laryngeal carcinoma.
Szczepański M, Stelmachowska M, Stryczyński L, Golusiński W, Samara H, Mozer-Lisewska I, Zeromski J. Szczepański M, et al. Eur Arch Otorhinolaryngol. 2007 May;264(5):525-30. doi: 10.1007/s00405-006-0215-7. Epub 2006 Dec 13. Eur Arch Otorhinolaryngol. 2007. PMID: 17165086 - Alternative activation of human plasmacytoid DCs in vitro and in melanoma lesions: involvement of LAG-3.
Camisaschi C, De Filippo A, Beretta V, Vergani B, Villa A, Vergani E, Santinami M, Cabras AD, Arienti F, Triebel F, Rodolfo M, Rivoltini L, Castelli C. Camisaschi C, et al. J Invest Dermatol. 2014 Jul;134(7):1893-1902. doi: 10.1038/jid.2014.29. Epub 2014 Jan 17. J Invest Dermatol. 2014. PMID: 24441096 - A novel TLR-9 agonist C792 inhibits plasmacytoid dendritic cell-induced myeloma cell growth and enhance cytotoxicity of bortezomib.
Ray A, Tian Z, Das DS, Coffman RL, Richardson P, Chauhan D, Anderson KC. Ray A, et al. Leukemia. 2014 Aug;28(8):1716-24. doi: 10.1038/leu.2014.46. Epub 2014 Jan 30. Leukemia. 2014. PMID: 24476765 Free PMC article. - Role of Chemokines in Thyroid Cancer Microenvironment: Is CXCL8 the Main Player?
Rotondi M, Coperchini F, Latrofa F, Chiovato L. Rotondi M, et al. Front Endocrinol (Lausanne). 2018 Jun 21;9:314. doi: 10.3389/fendo.2018.00314. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29977225 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical
Research Materials